ArticleIn vivo (Athens, Greece)

Inflammation-based Prognostic Score as a Prognostic Biomarker in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Treated With Nivolumab Therapy.

Mioko Matsuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.